Search the Newsreel

VeriSign Inc. stock outperforms competitors on strong trading day

VeriSign Inc. (VRSN) saw its stock rally by 1.49% to $287.15, outperforming the broader market which also experienced a favorable trading day. This rise ended a three-day losing streak for the company. The S&P 500 Index rose by 0.65% and the Dow Jones Industrial …

Verisk Analytics (VRSK) Eps Diluted (Quarterly)

Xeris (XERS) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Senior Vice President of Investor Relations - Allison Wey Chairman and Chief Executive Officer - John Shannon Chief Financial Officer - Steven Pieper Full Conference Call Transcript Operator: …

VeriSign CEO James Bidzos Sells 3,300 Shares for $979,000

VeriSign CEO James Bidzos sold 3,300 shares of the company's common stock for $979,000, as reported in an SEC Form 4 filing. This sale represents a minor adjustment to his holdings, impacting 0.8% of his direct shares, but occurred during a period of strong …

Is VRSK Worth Buying as Recurring Revenue Battles a Premium Valuation?

Verisk Analytics (VRSK) presents a durable subscription model with strong cash generation, but its premium valuation raises questions about its justification. While subscription revenues and product investments offer predictability, the company faces increased financing costs and operating expenses, requiring strong execution to maintain its …

Verisk's AI Expansion Gains Traction as Insurance Adoption Scales

Verisk (VRSK) is significantly expanding its AI integration within the insurance sector, with increased adoption of its XactAI platform and the rollout of Core Lines Reimagine modules. The company is seeing positive indicators in subscription revenue growth and upward revisions in earnings estimates, suggesting …

AQR Capital Management (VRSN) discloses 5.44% beneficial ownership in Verisign

AQR Capital Management, LLC and its parent company AQR Capital Management Holdings, LLC have disclosed a 5.44% beneficial ownership stake in Verisign, Inc., totaling 4,949,848 common shares. This information comes from a Schedule 13G SEC filing, indicating shared voting power over 4,609,654 shares and …

Anteris Technologies Global Corp. (ASX:AVR) Share Price Falls 4.05% as Stock Trades Within Daily Range

Adheris Health Ltd (ASX: AHE) Share Price Slips 5.88% in Latest Session

Verisk (VRSK) Tried to Walk Away From a $2.35 Billion Deal. A Judge Sent It Back

Verisk Analytics, Inc. (NASDAQ:VRSK) believed it had made a clean break from its $2.35 billion cash deal. A Delaware judge just told the data-analytics company otherwise, ordering it to return to the altar. The issue dates back to July 2025, when Verisk agreed to …

STERIS (STE) Could Be 10% Undervalued Following Strong Results And $600 Million Expansion

Arteris | 144: Notice of proposed sale of securities pursuant to Rule 144

This article is a notice of a proposed sale of securities by Arteris, filed pursuant to Rule 144. It indicates that the company is intending to sell securities as per regulatory requirements.

Investors Can Find Comfort In Verisk Analytics' (NASDAQ:VRSK) Earnings Quality

Despite reported weak earnings, an analysis of Verisk Analytics (NASDAQ:VRSK) suggests optimism due to the overall quality of its income statement, particularly its strong free cash flow relative to profit. The company's accrual ratio of -0.13 indicates that its statutory earnings were less than …

STERIS (NYSE:STE) Director Sells $956,795.24 in Stock

STERIS (NYSE:STE) Director Mohsen Sohi sold 4,058 shares of the company's stock for a total of $956,795.24, reducing his direct holdings by 14.31% to 24,305 shares. This transaction followed the company's strong earnings report, where STERIS beat analyst EPS estimates and saw revenue rise …

Insider (AIP) files Form 144 notice for 200-share stock sale

Nicholas B. Hawkins, an insider at Arteris, Inc. (AIP), has filed a Form 144 notice to sell 200 shares of common stock through Morgan Stanley Smith Barney LLC on August 12, 2026, with an aggregate market value of $5,800. These shares stem from restricted …

STERIS plc (STE) director Holland receives 1,025 Career Restricted Stock Units

STERIS plc director Christopher S. Holland was granted 1,025 Career Restricted Stock Units (RSUs). These RSUs are fully vested immediately and represent the right to receive one ordinary share each, to be settled six months after his Board service concludes. Following this grant, Holland …

STERIS plc (STE) director Pierre Boulud receives 1,025 Career RSUs

STERIS plc director Pierre Boulud was granted 1,025 Career Restricted Stock Units (RSUs), which are fully vested immediately but will be settled in ordinary shares six months after he ceases Board service. This grant brings his total direct RSU holdings to 1,392 units. Each …

Xeris Biopharma (XERS) insider Steven Pieper plans Rule 144 sale of 20,000 shares

Xeris Biopharma insider Steven Pieper has filed to sell 20,000 common shares under Rule 144, with an aggregate market value of $167,800.00, to be handled by Morgan Stanley Smith Barney LLC. These shares originated from Restricted Stock Units granted in January 2025. This planned …

STERIS plc SEC Filing (Aug 12, 2026)

This article reports on an SEC Form 144 filing by STERIS plc (STE) on August 12, 2026, detailing a proposed sale of 4058 shares of ordinary stock by an individual through an employee stock option exercise. The filing, which has a neutral impact and …

Anteris Technologies Q2 Loss Narrows, Net Sales Rise

Anteris Technologies (ASX: AVR) reported a narrowed loss of A$14.8 million for the second quarter, an improvement from the A$17.1 million loss in the prior-year period. The company also saw a significant increase in net sales, which rose to A$13.4 million from A$0.5 million …

Anteris Technologies Global (NASDAQ:AVR) Shares Down 4.3% Following Weak Earnings

Anteris Technologies Global (NASDAQ:AVR) shares dropped 4.3% after reporting disappointing second-quarter earnings, missing analyst expectations for both EPS and revenue. The company reported a loss of $0.30 per share on $1.01 million in revenue, compared to estimates of a $0.21 loss and $1.50 million …

Texas Civil Court Compelled Verisign to Lock .com Domain, Giving Every State Same Power

A Texas civil court has compelled Verisign, the operator of all .com domains, to lock motherless.com after its foreign operator ignored a default judgment. This action bypasses traditional enforcement challenges against overseas defendants by using Verisign's U.S. presence, effectively creating a template for any …

Here's Why You Should Retain VRSK Stock in Your Portfolio Now

Shares of Verisk Analytics, Inc. VRSK have had a decent run over the past three months. The stock has risen 12.1%, outperforming the industry's 9.1% growth. The Zacks S&P 500 composite has risen 3% over the said time frame. VRSK has a Growth Score …

Aeris Resources (ASX:AIS) Shares Climbed, What Is Driving Fresh Attention?

Cherish Sunshine Delays Completion of New Share Placing to 18 August 2026

Assenagon Asset Management S.A. Invests $6.35 Million in Anteris Technologies Global Corp. $AVR

Assenagon Asset Management S.A. has acquired a new stake of 644,668 shares, worth approximately $6.35 million, in Anteris Technologies Global Corp. (NASDAQ:AVR). This investment gives Assenagon Asset Management a 0.66% ownership in the company, while major shareholder L1 Capital recently sold 558,633 shares for …

Ameriserv Financial Inc (ASRV) Earnings Forecast: Future EPS & Revenue Growth Estimates

Anteris Technologies Announces Results for the Second Quarter of 2026

Anteris Technologies Global Corp. (NASDAQ: AVR, ASX: AVR) reported its financial results for the second quarter ended June 30, 2026, alongside a corporate update highlighting significant progress in its global pivotal PARADIGM Trial. Key achievements include securing U.S. Medicare reimbursement eligibility, initiating U.S. patient …

Anteris Technologies advances PARADIGM Trial in June quarter as US patient recruitment gets underway

Anteris Technologies made significant progress in its PARADIGM Trial during the June quarter, beginning US patient recruitment and expanding internationally. The company secured Medicare reimbursement eligibility for qualifying procedures in the US, facilitating patient enrollment. The trial, which compares Anteris' DurAVR® Transcatheter Heart Valve …

Wrapped Verisk Analytics Tokenized Stock (xStock) price today, wVRSKx to USD live price, marketcap and chart

This CoinMarketCap page provides live price, market cap, and chart information for Wrapped Verisk Analytics Tokenized Stock (xStock), identified by the symbol wVRSKx. It indicates that the token currently has a total supply and circulating supply of 0, with a maximum supply not provided. …

Insider Selling: VeriSign (NASDAQ:VRSN) EVP Sells 500 Shares

VeriSign (NASDAQ:VRSN) EVP Thomas Indelicarto sold 500 shares of the company's stock for $146,175. The transaction, conducted under a pre-arranged Rule 10b5-1 plan, reduced his holdings by 1.43%. VeriSign recently reported strong quarterly earnings and announced a dividend, while analysts maintain a positive outlook …

VeriSign (VRSN) EVP Indelicarto sells 500 shares in Rule 10b5-1 trade

VeriSign Inc.'s EVP, General Counsel & Secretary, Thomas C. Indelicarto, sold 500 shares of common stock on August 10, 2026, at $292.35 per share. This transaction, executed under a Rule 10b5-1 trading plan, leaves him with 34,551.0439 shares directly held. The filing suggests a …

Anteris Technologies Global (NASDAQ:AVR) Releases Earnings Results, Misses Estimates By $0.09 EPS

Anteris Technologies (AVR) boosts cash to $260.9M while losses mount in DurAVR valve push

Anteris Technologies reported a Q2 2026 operating loss of $55.0 million and a net loss of $51.7 million, with increased R&D and SG&A expenses driven by the DurAVR® transcatheter heart valve system development and global pivotal trial. Despite these losses, the company significantly boosted …

VeriSign Inc. stock underperforms Tuesday when compared to competitors

VeriSign Inc. (VRSN) stock fell 1.95% on Tuesday, closing at $287.63. This underperformance occurred on a generally down day for the market, with both the S&P 500 Index and Dow Jones Industrial Average also recording losses. This marks the second consecutive day of losses …

Verisk Stock (NASDAQ:VRSK) Loses $1.39 Billion as Court Revives AccuLynx Deal

Verisk (NASDAQ:VRSK) shares dropped 5.55%, erasing $1.39 billion in market value, after a Delaware court revived its obligations to acquire AccuLynx for $2.35 billion. The ruling requires Verisk to seek antitrust clearance and covers AccuLynx's direct costs, but does not immediately close the deal. …